WDR4/TRIM28 is a novel molecular target linked to lenvatinib resistance that helps retain the stem characteristics in hepatocellular carcinomas
Weiyu Han, Jie Wang, Jing Zhao, Yi-Min Zheng, Xiaoqiang Chai, Chao Gao, Jiabin Cai, Ai‐Wu Ke, Jia Fan, Pingting Gao, Haixiang Sun, Haixiang Sun
Topics & Concepts
LenvatinibHepatocellular carcinomaCancer researchOncologyIn vivoMedicineBiologyInternal medicineGeneticsSorafenibCancer Mechanisms and Therapyinterferon and immune responsesUbiquitin and proteasome pathways